This activity is sponsored by UCB.
September 12, 2019
The term spondyloarthritis (SpA) encompasses a spectrum of related inflammatory conditions with a predominance of either axial or peripheral manifestations. The figure…go to activity»
Expiration Date: 8/30/2020
nAMD is an incurable disease and can lead to permanent vision loss. nAMD imposes a high burden on patients and eye care providers alike, as optimal visual outcomes have…go to activity»
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Expiration Date: 8/27/2020
The treatment of neovascular age-related macular degeneration (nAMD) has been revolutionized through the introduction of intravitreal anti–vascular endothelial growth…go to activity»
This activity is supported by independent medical education grants from Optos North America and Regeneron Pharmaceuticals, Inc.
Expiration Date: 6/1/2020
Diabetic retinopathy (DR) continues to be a leading cause of blindness. However, early diagnosis and prompt treatment with laser and/or intravitreal anti-vascular…go to activity»
This activity is supported by educational grants from Alcon Laboratories, Inc. and EyePoint Pharmaceuticals, Inc.
Expiration Date: 5/25/2020
New techniques for cataract surgery have emerged in rapid succession over the past few years. Some of these techniques have been demonstrated to provide clinically…go to activity»
This activity is supported by an educational grant from Genentech, Inc.
Expiration Date: 4/11/2020
Anti-VEGF therapy is an important addition to the treatment options for diabetic retinopathy (DR) and is the only medical option that has been granted US Food and Drug…go to activity»